TY  - JOUR
T1  - HYpertriglyceridemia and its pharmacologic treatment among us adults—invited commentary
AU  - Thompson WG, Gau GT
Y1  - 2009/03/23
N1  - 10.1001/archinternmed.2008.594
JO  - Archives of Internal Medicine
SP  - 578
EP  - 579
VL  - 169
IS  - 6
N2  - 
Should hypertriglyceridemia be treated, and if so, how? Several authors have advocated pharmacologic therapy and have cited the NCEP report.2 However, the NCEP report advocates pharmacologic treatment only for TG concentrations higher than 500 mg/dL. The report advocates lifestyle change for TG concentrations between 150 and 500 mg/dL and says that pharmacologic therapy can be considered in high-risk persons in this group.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2008.594
UR  - http://dx.doi.org/10.1001/archinternmed.2008.594
ER  -